Lantus insulin glargine. This is a once daily injection treatment for adults with type 2 diabetes who are unable Jan 9, 2017 · The recently FDA Approved Combination Drug Soliqua 100/33 is now available in US pharmacies by prescription. This is a once daily injection treatment for adults with type 2 diabetes who are unable . A PRNewswire-USNewswire press release states that Soliqua 100/33 is a combination of insulin glargine (Lantus) and the GLP-1 receptor agonist, lixisenatide (Adlyxin in the US and Lyxumia in Europe). Jan 9, 2017 · The recently FDA Approved Combination Drug Soliqua 100/33 is now available in US pharmacies by prescription. hivsssquzqlbjmq8ktbro2owdgd3vxwmth0kuuentozw